We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$3.99B
AUM Growth
-$465M
Cap. Flow
-$680M
Cap. Flow %
-17.06%
Top 10 Hldgs %
41.63%
Holding
165
New
26
Increased
36
Reduced
76
Closed
25

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$53.5M
2
AMX icon
America Movil
AMX
+$35.8M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
STZ icon
Constellation Brands
STZ
+$25.9M
5
ZTS icon
Zoetis
ZTS
+$22.5M

Top Sells

Rank Stock Value
1
INDA icon
iShares MSCI India ETF
INDA
+$56.3M
2
JD icon
JD.com
JD
+$50.6M
3
TCOM icon
Trip.com Group
TCOM
+$49.9M
4
BKNG icon
Booking.com
BKNG
+$42.6M
5
CX icon
Cemex
CX
+$39.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.94%
2 Financials 19.39%
3 Technology 18.97%
4 Communication Services 13.34%
5 Industrials 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABM icon
126
ABM Industries
ABM
$2.87B
$1.83M 0.05%
48,569
+3,273
+7% +$135K
SXT icon
127
Sensient Technologies
SXT
$5.54B
$1.82M 0.05%
24,940
-10,649
-30% -$812K
JOYY
128
JOYY Inc
JOYY
$3.77B
$1.46M 0.04%
+12,900
New +$1.29M
ARDX icon
129
Ardelyx
ARDX
$1.21B
$1.4M 0.04%
212,182
+28,955
+16% +$172K
BKNG icon
130
Booking.com
BKNG
$156B
$1.39M 0.03%
19,950
-588,425
-97% -$42.6M
ACRS icon
131
Aclaris Therapeutics
ACRS
$888M
$1.29M 0.03%
52,345
-19,089
-27% -$465K
WUBA
132
DELISTED
58.com Inc
WUBA
$1.27M 0.03%
+17,750
New +$1.23M
EWT icon
133
iShares MSCI Taiwan ETF
EWT
$10.6B
$1.21M 0.03%
+33,500
New +$1.24M
ERII icon
134
Energy Recovery
ERII
$457M
$1.18M 0.03%
+134,815
New +$1.23M
EHTH icon
135
eHealth
EHTH
$40M
$1.08M 0.03%
+62,355
New +$1.39M
CIB icon
136
Grupo Cibest SA
CIB
$21.4B
$652K 0.02%
16,430
-4,490
-21% -$182K
BBD icon
137
Banco Bradesco
BBD
$37.9B
$388K 0.01%
66,587
-22,506
-25% -$135K
VALE icon
138
Vale
VALE
$63.6B
$373K 0.01%
30,480
+9,677
+47% +$103K
ABEV icon
139
Ambev
ABEV
$46.8B
$300K 0.01%
46,500
-62,040
-57% -$397K
CHL
140
DELISTED
China Mobile Limited
CHL
$243K 0.01%
4,800
– –
AMN icon
141
AMN Healthcare
AMN
$1.27B
– –
-9,980
Closed -$456K
AORT icon
142
Artivion
AORT
$1.27B
– –
-139,957
Closed -$3.18M
ATRC icon
143
AtriCure
ATRC
$2B
– –
-126,406
Closed -$2.83M
CGNX icon
144
Cognex
CGNX
$11.8B
– –
-190,084
Closed -$10.5M
CMCSA icon
145
Comcast
CMCSA
$87.8B
– –
-729,500
Closed -$28.1M
CTSH icon
146
Cognizant
CTSH
$25.1B
– –
-2,783
Closed -$202K
CX icon
147
Cemex
CX
$16.7B
– –
-4,369,800
Closed -$39.7M
MELI icon
148
Mercado Libre
MELI
$97.5B
– –
-109,346
Closed -$28.3M
PCRX icon
149
Pacira BioSciences
PCRX
$991M
– –
-16,691
Closed -$627K
PEGA icon
150
Pegasystems
PEGA
$5.23B
– –
-194,160
Closed -$5.6M
3 4 5
6
7

Similar funds

A
Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return
VAS
Vestmark Advisory Solutions Wakefield, Massachusetts $9.02B AUM 20.58% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return
PEA
Platinum Equity Advisors Beverly Hills, California $8.88B AUM 27.09% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
RWP
RWA Wealth Partners Newton, Massachusetts $9.14B AUM 16.57% 1-Year Est. Return
MU
Mirova US Boston, Massachusetts $8.81B AUM 21.38% 1-Year Est. Return

Axiom Investors's Q4 2017 Portfolio in Review

As of Q4 2017, Axiom Investors held 165 positions worth $3.99B, down 10% from $4.45B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Axiom Investors withdrew a net $680M in Q4 2017, closing 25 positions and reducing 76 holdings. Its most notable exit was Cemex, an estimated $39.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

Against the trend, Axiom Investors opened a new position in Biogen worth $27.2M.

  • Axiom Investors's largest Q4 2017 buy was Biogen: 85,430 shares worth $27.2M.
  • Axiom Investors added most to NetEase in Q4 2017, an estimated $53.5M increase.
  • Axiom Investors's biggest Q4 2017 reduction was iShares MSCI India ETF, cutting an estimated $56.3M.
  • Axiom Investors fully exited Cemex in Q4 2017, selling an estimated $39.7M.
  • Axiom Investors's ten largest holdings make up 42% of its $3.99B portfolio in Q4 2017.
  • Axiom Investors opened 26 new positions and closed 25 in Q4 2017.
  • Axiom Investors's portfolio value fell 10% quarter-over-quarter to $3.99B.

Based on Axiom Investors's 13F filing for Q4 2017, filed 14 Feb 2018.